Your browser doesn't support javascript.
loading
The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
Yang, Wenchang; Liu, Qian; Lin, Guole; Zhang, Bo; Cao, Hui; Zhao, Yan; Xia, Lijian; Feng, Fan; Xiong, Zhiguo; Hu, Junbo; Ye, Yingjiang; Tao, Kaixiong; Zhang, Peng.
Afiliação
  • Yang W; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Liu Q; Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Lin G; Department of General Surgery, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
  • Zhang B; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Cao H; Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhao Y; Department of Gastric Surgery, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Shenyang, China.
  • Xia L; Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Feng F; Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, China.
  • Xiong Z; Department of Gastrointestinal Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Hu J; Department of Gastrointestinal Surgery, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Ye Y; Department of Gastrointestinal Surgery, People's Hospital, Peking University, Beijing, China.
  • Tao K; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zhang P; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
J Surg Oncol ; 124(7): 1128-1135, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34324197
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Surg Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Surg Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China